ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 300

$1.15M Total Retail Price of All Prescriptions

Rank: 7 out of 300

706 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 706 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 706 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 4,890 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$132 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
GABAPENTIN 784 542 1 7
NAMENDA 499 466 2 48
HYDROCODONE-ACETAMINOPHEN 483 137 S3 3 1
CARBIDOPA-LEVODOPA 457 382 4 80
TOPIRAMATE 362 124 5 85
CYMBALTA 282 152 6 37
LYRICA 262 150 7 55
LEVETIRACETAM 247 147 8 91
CLOPIDOGREL 210 185 9 18
DONEPEZIL HCL 186 164 10 57
EXELON 182 157 11 123
PLAVIX 158 134 12 24
PRAMIPEXOLE DIHYDROCHLORIDE 138 100 13 130
DILANTIN 138 77 13 241
AGGRENOX 133 121 15 200
ROPINIROLE HCL 123 105 16 121
CARISOPRODOL 121 0 R 17 36
PHENYTOIN SODIUM EXTENDED 120 67 18 164
AMITRIPTYLINE HCL 115 67 R 19 66
TIZANIDINE HCL 114 19 20 42
OXYCODONE HCL 113 0 S2 21 30
PREDNISONE 100 93 22 33
ZOLPIDEM TARTRATE 95 20 23 21
ZONISAMIDE 92 52 24 181
MIRTAZAPINE 91 53 25 152
TRAMADOL HCL 88 53 26 23
CITALOPRAM HBR 87 42 27 54
CYCLOBENZAPRINE HCL 86 0 R 28 71
VIMPAT 82 14 29 220
PRAVASTATIN SODIUM 78 63 30 15
BACLOFEN 77 0 31 106
DIVALPROEX SODIUM 72 0 32 149
ESCITALOPRAM OXALATE 70 18 33 78
COMTAN 69 45 34 386
PROPRANOLOL HCL 69 59 34 236
SERTRALINE HCL 62 48 36 41
SUMATRIPTAN SUCCINATE 57 0 37 417
SIMVASTATIN 56 38 38 5
QUETIAPINE FUMARATE 56 36 38 79
PRIMIDONE 52 40 40 211
NORTRIPTYLINE HCL 52 51 40 302
OXYCODONE HCL-ACETAMINOPHEN 52 28 S2 40 62
AZILECT 50 38 43 277
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.